阿尔法脂酸补充剂改善了弗里德里希的细胞模型中的病理变化
Marta Talaverón-Rey1, Diana Reche-López1, Suleva Povea-Cabello1,2
1Centro Andaluz de Biología del Desarrollo (CSIC-Junta de Andalucía-UPO), Universidad Pablo de Olavide, 41013, Seville, Spain.
Orphanet journal of rare diseases
|August 23, 2025
概括
通过部分纠正细胞缺陷,阿尔法脂酸 (ALA) 在治疗弗里德里希心动症 (FRDA) 中表现有前途. 这种抗氧化剂可能会增加FRDA模型中的frataxin表达并逆转疾病表型.
科学领域:
- 神经科学
- 遗传学
- 线粒体生物学
背景情况:
- 弗里德里希缺血症 (FRDA) 是一种自体递归的神经退行性疾病.
- FRDA是由frataxin (FXN) 基因的表达减少引起的.
- 病理生理学涉及线粒体功能障碍,氧化应激和能量产生障碍.
研究的目的:
- 评估阿尔法脂酸 (ALA) 对于逆转FRDA相关的病理变化.
- 研究ALA对FRDA患者的纤维细胞和诱导神经元的影响.
主要方法:
- 评估铁的积累,脂质过氧化和frataxin水平.
- 检查了线粒体蛋白质表达和生物能学.
- 使用患者衍生的纤维细胞和诱导的神经元.
主要成果:
- 治疗ALA部分纠正了FRDA纤维细胞和神经元的病态变化.
- 在FXN基因中,最佳ALA度与GAA三重重复数相关.
- ALA的作用可能由氧酶增殖器激活受体玛 (PPARγ) 激活.
结论:
- 在FRDA细胞模型中,ALA治疗可以增强frataxin的表达.
- 在FRDA中,ALA具有逆转突变表型的潜力.
- ALA代表了弗里德里希的潜在治疗药物.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


